Cargando…
Xanthohumol, a Prenylated Flavonoid from Hops, Induces Caspase-Dependent Degradation of Oncoprotein BCR-ABL in K562 Cells
BCR-ABL oncoprotein drives the initiation, promotion, and progression of chronic myelogenous leukemia (CML). Tyrosine kinase inhibitors are the first choice for CML therapy, however, BCR-ABL mediated drug resistance limits its clinical application and prognosis. A novel promising therapeutic strateg...
Autores principales: | Lu, Xuxiu, Geng, Jiajia, Zhang, Jinman, Miao, Jinlai, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769755/ https://www.ncbi.nlm.nih.gov/pubmed/31527518 http://dx.doi.org/10.3390/antiox8090402 |
Ejemplares similares
-
Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus)
por: Liu, Ming, et al.
Publicado: (2015) -
Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)
por: Jiang, Chuan-Hao, et al.
Publicado: (2018) -
Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets
por: Lee, Ye-Ming, et al.
Publicado: (2012) -
Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro
por: Wei, Shanshan, et al.
Publicado: (2018) -
Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells
por: Liu, Ming, et al.
Publicado: (2016)